Compare Ascendis Pharma A/S (ASND) vs Global X Lithium & Battery Tech ETF (LIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Global X Lithium & Battery Tech ETF — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Global X Lithium & Battery Tech ETF trades at $75.2. Which is the better fit depends on your goals.
| ASND | LIT | |
|---|---|---|
Market Cap | $16.67B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $277.18 | $91.62 |
52-Week Low | $189.74 | $44.96 |
Enterprise Value | $17.04B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →
